Szymon Przerada

Szymon Przerada is an experienced professional in the pharmaceutical field, currently serving as the Head of Formulation Development Team at Polpharma since January 2012. In this role, Szymon has focused on the development of generic solid dosage forms, production technology transfer, and troubleshooting formulation and process issues. Prior to this, Szymon worked as a Pharmacist and Manager at Apteka Staromiejska where responsibilities included medication compounding, dispensing prescription medications, and patient education on drug use. Szymon also completed a Master Thesis Project at Uppsala University, investigating the IFNAR-1 gene in breast cancer patients, which involved various molecular biology techniques. Szymon holds a Master's degree in Pharmacy from Gdański Uniwersytet Medyczny, earned between 2005 and 2011.